Benzodiazepine Discontinuation Difficulties in Panic Disorder: Conceptual Model and Outcome for Cognitive-Behavior Therapy
Authors: Otto, M.W.; Hong, J.J.; Safren, S.A.
Source: Current Pharmaceutical Design, Volume 8, Number 1, 1 January 2002 , pp. 75-80(6)
Publisher: Bentham Science Publishers
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
There is consistent support for the efficacy of cognitive-behavior therapy (CBT) to aid the successful discontinuation of benzodiazepine (BZ) medication in patients with panic disorder, and help these individuals maintain treatment gains while off medication. In this article, we provide a conceptual model for BZ discontinuation difficulties in patients with panic disorder. Outcome studies are reviewed, and are placed in the context of other evidence for the efficacy of CBT in patients with this disorder.
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help